fda tirzepatide update Compounding Update: Reversal & What Pharmacies Need to Know! FDA Approves Tirzepatide (Zepbound) as

The loss of joy GLP-1s help people lose weight through several mechanisms, which include reducing peoples cravings for food

More serious but less common adverse effects require clinical vigilance

showed that each 10 C increase in mean 30-day temperature was associated with 1.06 times higher odds of gestational diabetes mellitus [14]

Red flag symptoms requiring urgent medical assessment include: Severe abdominal pain or distension , particularly if accompanied by vomiting Complete inability to pass stools or wind (absolute constipation), especially with pain or distension Rectal bleeding or blood in the stool Unexplained weight loss beyond that expected from the medication's therapeutic effect Persistent nausea and vomiting preventing adequate oral intake Signs of bowel obstruction , such as colicky pain, absolute constipation, and abdominal distension Severe persistent abdominal pain radiating to the back , which may indicate pancreatitis Right upper abdominal pain, fever or yellowing of the skin/eyes , which could suggest gallbladder problems For urgent advice, contact NHS 111 or your GP